Biotechnology in the Time of COVID-19: Commentaries from the Front Line

by Jeremy M. Levin

BeiGene Ltd. (Nasdaq: BGNE; HKEX: 06160) is a global biotechnology company. Its 3,800+ employees are developing novel cancer medicines to improve outcomes and access for patients worldwide.